Artificial Intelligence in Genomics Market worth $1,671 million by 2025

According to the new market research report Artificial Intelligence In Genomics Market by Offering (Software, Services),Technology (Machine Learning, Computer Vision), Functionality (Genome Sequencing, Gene Editing), Application (Diagnostics), End User (Pharma, Research) - Global Forecasts to 2025, published by MarketsandMarkets™, the global AI in Genomics market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025

Browse in-depth TOC on "Artificial Intelligence in Genomics Market"
141 – Tables
24 – Figures
154 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899

The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.

Machine learning to dominate the AI in Genomics market in 2019

Based on technology, the Artificial Intelligence in Genomics Market is segmented into machine learning and other technologies. The machine learning segment dominated this market in 2019, as pharmaceutical companies, CROs, and biotechnology companies have widely adopted machine learning for drug genomics applications. This is because machine learning can extract insights from data sets, accelerating genomic research.

Diagnostics segment accounted for the largest share of the AI in Genomics market, by end user, in 2019

Based on application, the Artificial Intelligence in Genomics Market is segmented into diagnostics, drug discovery & development, precision medicine, agriculture & animal research, and other applications. Diagnostics was the largest application segment in genomics market in 2019. The large share of this segment can be attributed to the increasing research on diseases and the decreasing cost of sequencing.

North America is the largest regional market for AI in Genomics in 2019

In 2019, North America accounted for the largest share of the AI in Genomics market, followed by Europe. The large share of North America can be attributed to the increasing research funding and government initiatives for promoting precision medicine in the US.

Prominent players in the Artificial Intelligence in Genomics Market are IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK),Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), Engine Biosciences Pte. Ltd. (US)

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=36649899

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Single use Bioreactors Market worth $8.8 billion by 2026

According to the new market research report Single use Bioreactors Market by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) - Global Forecast to 2026, published by MarketsandMarkets™, the global Single-Use Bioreactors Market is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750

Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market.

Single-use bioreactor systems accounted for the largest share of single use bioreactors market

Based on product, the single-use bioreactors market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. The single-use bioreactor systems segment dominated the market in 2020. SUB systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharma applications.

Stirred-tank SUBs accounted for the largest share of single-use bioreactors market

Based on type, the single-use bioreactors market is categorized into wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs segment dominated the single-use bioreactors market in 2020. The stirred-tank SUBs are highly preferred in the cultivation of aerobic microbial cultures as it promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.

The contract research organizations (CROs) and contract manufacturing organizations (CMOs) is the fastest-growing end user segment of the single-use bioreactors market

Based on end users, the single use bioreactors market is segmented into pharmaceutical & biopharmaceutical companies, contract research organizations and contract manufacturing organizations (CROs and CMOs), and academic & research institutes. The contract research organizations (CROs) and contract manufacturing organizations (CMOs) segment is projected to register the highest CAGR in the single-use bioreactors market during the forecast period. The increasing outsourcing of R&D and manufacturing services by pharmaceutical and biopharmaceutical companies is expected to support the growth of the CROs & CMOs segment.

North America accounted for the largest share of the market

North America accounted for the largest share of the single-use bioreactors market, followed by Europe in 2020. The large share of the North American regional segment can be attributed to the presence of a well-established biopharmaceutical industry and major players operating in the single-use bioreactors market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750

The prominent players operating in the single use bioreactors market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Disposable Medical Device Sensors Market Leading Players and Business Trends

According to the new market research report Disposable Medical Device Sensors Market is projected to reach USD 9.4 billion by 2026 from USD 6.5 billion in 2021, at a CAGR of 7.7% during the forecast period.

Market growth is largely driven by rising concerns over hospital-acquired infections and contamination, the increasing incidence of target conditions, the growing demand for home-based medical care devices, significant technological advancements in the last few years, and government support for R&D activities for these devices. The emerging markets in developing countries are also expected to provide growth opportunities for players in the disposable medical device sensors market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1259

However, the vulnerability of connected medical devices in terms of data leakages, government regulations, and the long certification and approval cycles are major challenges faced by the market.

The disposable medical device sensors market is a competitive market, with few large as well as emerging players. The prominent players in this market are Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Medtronic (Ireland), Texas Instrument (US), Platinum Equity Advisors LLC (US), NXP Semiconductors (Netherlands), General Electric Company (US), TE Connectivity (Switzerland), STMicroelectronics (Switzerland), Honeywell International Inc. (US), Analog Devices, Inc. (US), Smiths Group Plc (UK), and Koninklijke Philips N.V. (Netherlands).

ABBOTT (US)

Abbott was ranked first in the disposable medical device sensors market in 2020. It is a global, diversified healthcare company dedicated to discovering, developing, manufacturing, and marketing pharmaceuticals, nutritional products for children and adults, and medical products such as devices, diagnostic tests, and instruments. Abbott provides continuous glucose and blood glucose monitoring systems under the FreeStyle brand. The company focuses on building country-specific portfolios made of high-quality products that meet the needs of people in emerging markets.

F. HOFFMANN-LA ROCHE LTD. (SWITZERLAND)

Roche held the second position in the disposable medical device sensors market in 2020. The company offers the industry’s most comprehensive in-vitro diagnostics solutions, covering clinical chemistry and immunoassays, molecular and digital diagnostics, point-of-care testing, patient self-testing, next-generation sequencing, laboratory automation and IT, and decision support. Roche serves customers spanning the entire healthcare spectrum—from hospitals, commercial laboratories, and research institutions to physicians and patients. Roche Diabetes Care aids people with diabetes and healthcare professionals through innovative Accu-Chek products and impactful solutions for convenient, efficient, and effective diabetes management. This includes blood glucose meters, lancing devices, insulin delivery systems, and digital solutions for data management, advice, coaching, and education.

Based on products, the medical device sensors market is segmented into biosensors, accelerometers, temperature sensors, image sensors, and other sensors. The biosensors segment accounted for the largest share in 2020.

Based on applications, the disposable medical device sensors market is segmented into patient monitoring, diagnostic testing, therapeutics, and imaging. The diagnostic testing segment accounted for the largest share in 2020. The large share of this application segment can primarily be attributed to the rising incidence of lifestyle diseases across the globe.

Based on type, disposable medical device sensors are segmented into strip sensors, wearable sensors, invasive sensors, and ingestible sensors. The strip sensors segment accounted for the largest share of the market in 2020.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1259

The medical device sensors market is divided into five regions, namely, North America, Europe, Asia Pacific, and Rest of the World. North America dominated the global market. The large share of the North American region is mainly attributed to the rising incidence of HAIs and chronic diseases in the region. Further, the availability of technologically advanced sensor-based disposable medical devices due to the presence of major players in the North American region also support the market growth.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

eHealth Market Leading Players and Business Trends

According to the new market research report eHealth Market is projected to reach USD 193.8 billion by 2025 from USD 69.5 billion in 2020, at a CAGR of 22.8% during the forecast period.

Factors such as the increased adoption of eHealth solutions, rising elderly population base, and the growing number of infectious diseases are expected to drive the growth of the eHealth market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11513143

Players in the global eHealth industry include Cerner (US), McKesson (US), Philips Healthcare (Netherlands), GE Healthcare (US), and Allscripts (US). Other leading players in this market include athenahealth (US), Epic Systems (US), IBM (US), Optum (US), Siemens Healthineers (Germany), Medtronic (Ireland), and Cisco Systems (US).. These players are focusing on increasing their presence in high-growth markets through both organic as well as inorganic growth strategies, including service launches, expansions, collaborations, and partnerships.

GE Healthcare (US) held significant poistion in the global eHealth market in 2019. GE Healthcare is a leading provider of eHealth solutions. It has a strong and robust product and service portfolio of EHR and EMR solutions and services; PACS and VNA solutions; and health information exchange solutions. The company concentrates on R&D activities. It focuses on developing new and improved products and services. GE Healthcare has launched 25 new products, services, and digital solutions in the market. Such initiatives undertaken by the company provide it a competitive edge over other players operating in the eHealth market and help it maintain its foothold in the market.

Cerner (US) also accounted for considerable market share in eHealth market in 2019. Cerner has a robust eHealth solutions portfolio tailored for medium- and large-sized healthcare enterprises to help them with advanced software and services, designed specifically to cater to their requirements. The key strength of the company is its wide geographic presence and extensive distribution network across leading markets. Cerner has a strong global presence. Approximately 88.0% of its revenue is generated from North America. However, the company is focusing on expanding its operations in non-US markets, along with entering new markets through business expansions and the adoption of inorganic growth strategies.

Based on end user, the eHealth market has been segmented into healthcare providers, healthcare payers, healthcare consumers, pharmacies and other end-users of these, healthcare providers segment accounted for the largest share of the eHealth solutions market in 2019. Healthcare providers include hospitals, ASCs and home healthcare agencies. High segmental market share can is attributable to the increasing hospital and out-patient admissions.

Based on eHealth solutions, EHR/EMR Solutions, Medical Apps, Picture Archiving and Communication, Systems & Vendor Neutral Archive, Chronic Care Management Apps, PHR & Patient Portals, Health Information Exchange Solutions, Telehealth Solutions, Pharmacy Information Systems, Laboratory Information Systems, Clinical Decision Support Systems, E-Prescribing Solutions, Radiology Information Systems, Cardiovascular Information Systems and Other Specialty Information Systems The market for EHR/EMR segment is expected to grow significantly in the forthcoming years.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=11513143

Geographically, the North American eHealth Market accounted for the largest share of the eHealth solutions market in 2019 due to the presence of a well-established base of eHealth companies, high investments in the several healthcare IT, and increasing R&D expenditure. The Asia Pacific market is expected to register the highest growth during the forecast period due to increasing healthcare expenditures and improving regulatory scenario.
Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Spirometer Market Top Players and Business Intelligence

According to the new market research report Spirometer Market is projected to reach USD 1,285 million by 2025 from USD 799 million in 2020, at a CAGR of 11.1%.

Growth in this market is largely driven by the rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition. On the other hand, dependence on patient and other human interventions for data will hinder the growth of this market and will remain a challenge.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659

The spirometer market isconsolidated in nature. The major players operating in this market are Hill Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), ndd Medical Technologies (Switzerland), Vitalograph (UK), and Midmark Corporation (US).

Hill-Rom is the largest player in the spirometer market. The company focuses on the development of devices, consumables, accessories, and software required to perform spirometer tests. These products are sold under the brand Welch Allyn. The company also invests a significant amount on research and development activities.

Vyaire Medical is a pioneer in the spirometer market. As a result, it has a strong foothold in the spirometer devices market. The company was formed by a partnership between BD and Apax Fund Partners, when BD divested its respiratory care business. Apax Fund Partners took over the complete holdings of Vyaire Medical in 2019. Vyaire Medical has a global distribution network and has a good brand reputation among end users.

Based on product, the spirometer market is segmented into devices, consumables & accessories, and software. This segment is expected to witness the highest growth rate during the forecast period.

Based on mechanism, the spirometer market is segmented into flow-sensing spirometer and peak flow meters. The flow- sensing segment accounted for the highest share in 2019.

Request For Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=18015659

The global spirometer market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). The North American market is expected to account for the highest market share in 2019. The large share of this market segment can be attributed to the increasing incidence of chronic respiratory diseases and the rising adoption of technologically advanced devices in the region.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

 

X-Ray Detectors Market Insights on Scope and Growing Demands 2024

According to research report the global X-Ray Detectors Market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1% during the forecast period.

Factors such as declining prices and benefits offered by digital detectors, growing public and private investments in Digital Imaging technologies and reimbursement cuts for analog X-rays are driving the growth of the X-ray detectors market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984

Based on type, the market is segmented into flat-panel detectors (FPDs), computed radiography (CR) detectors, charge-coupled device (CCD) detectors, and line-scan detectors. In 2019, the flat-panel detectors segment is expected to account for the largest share of the X-ray detectors market. The growth in this market is mainly driven by the advantages offered by FPD-based portable digital systems (such as high-quality images, faster scanning, increased patient throughput, and multiple storage options), their decreasing prices, and the growing demand for retrofit FPD-based digital X-ray systems.

By application, the market is segmented into medical, dental, security, veterinary, and industrial applications. The medical applications segment is expected to grow at the highest rate during the forecast period. The growth in this segment can primarily be attributed to the advancements in medical technology, rising geriatric population, and the increasing number of orthopedic and cardiovascular procedures.

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Recent Developments

> In May 2017, Varex Imaging Corporation acquired PerkinElmer's medical imaging business to expand its digital flat-panel detectors business.
> In December 2016, Canon Inc. acquired Toshiba Medical Systems Corporation to enhance its position in the healthcare industry.

The X-ray detectors market is highly competitive with several big and small players. Prominent players in this market include Varex Imaging Corporation (US), Thales Group (France), Canon, Inc. (Japan), Fujifilm Holdings Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Vieworks Co., Ltd (South Korea), Hamamatsu Photonics K.K. (Japan), Konica Minolta, Inc. (Japan), Teledyne DALSA Inc. (US), Analogic Corporation (US), Rayence (South Korea), and DRTECH (South Korea).

Recent Developments

> In May 2017, Varex Imaging Corporation acquired PerkinElmer's medical imaging business to expand its digital flat-panel detectors business.
> In December 2016, Canon Inc. acquired Toshiba Medical Systems Corporation to enhance its position in the healthcare industry.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=7004984

In 2019, North America is expected to account for the largest share of the X-ray detectors market, followed by Europe, Asia, and the RoW. The large share of North America is attributed to factors such as technological innovations, increasing healthcare spending, availability of venture capital and government funding, and increasing incidence of chronic diseases in the region.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Coronary Stents Market Insights on Scope and Growing Demands 2021

According to the research report the Coronary Stents Market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021.

Major factors driving the growth of this market include technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market provide significant growth opportunities in the market.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=77411272

Technological advancements, increasing demand for minimally invasive procedures and rapid growth in geriatric population are the major drivers for the market.

The coronary stents market is witnessing a new phase of technological developments, with the launch of fully dissolving stents. In July 2016, Abbott (US) received US FDA approval to commercially launch its Absorb bioresorbable heart stent. Absorb is the only fully dissolving stent approved for the treatment of CAD. Moreover, researchers have also developed dual-therapy stents and bioengineered stents for the treatment of CAD. Innovations in stenting technology, in terms of material, construction, and coatings play a major role in increasing the effectiveness of stents and expanding their application areas. Moreover, launching innovative products in the market helps companies gain a competitive advantage and drive the uptake of their products.

Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bioabsorbable stents. The drug-eluting stents segment is expected to account for the largest share of the coronary stents market in 2016. This can primarily be attributed to the advantages of drug-eluting stents over bare-metal stents, such as lower risk of restenosis and other related complications. Based on mode of delivery, the Coronary Stents Market is segmented into balloon-expandable stents and self-expanding stents. The balloon expandable stents segment is expected to grow at the highest CAGR during the forecast period due to factors such as increasing research activities to improve this technology, high utilization of these stents, and growing regulatory approvals for balloon-expandable stents.

Based on region, the Coronary Stent Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to dominate the market, followed by Europe. Asia is poised to be the fastest-growing region during the forecast period. Factors such as large population base, growing prevalence of cardiac diseases, rising adoption of advanced technologies, and low manufacturing costs in the region are expected to drive market growth in Asia. Moreover, the growing focus of major players in this region is expected to boost the coronary stents market in Asia.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=77411272

The Coronary Stents Market is a highly fragmented market, with several big and emerging players. Key market players include Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), B. Braun Melsungen AG (Germany), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Medical Image Management Market Insights on Scope and Growing Demands 2023

According to research report the medical image management market is projected to reach USD 4.40 billion in 2023 from USD 3.04 billion in 2018 at a CAGR of 7.7% during the forecast period.

The growth of the market is driven by the technological advancements in diagnostic imaging modalities and image management software, growing investments in the medical imaging market, government initiatives to encourage EMR adoption, increasing usage of imaging equipment, and the growing adoption of image management systems by small hospitals and imaging centers, are factors driving the growth of the medical image management market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=240573338

The report segments the medical image management system market by product, end user, and region.

Based on products, the medical image management market is segmented into PACS, VNAs, AICA, and enterprise/universal viewers. The PACS segment is expected to account for the largest share of the market in 2018. Factors such as technological advancements in PACS: adoption of PACS in new imaging segments such as endoscopy, ophthalmology, mammography, and oncology; growing adoption of PACS by small hospitals and imaging centers; and government initiatives encouraging Healthcare IT adoption are driving the growth of the PACS segment.

On the basis of type, the PACS market is segmented into radiology PACS, cardiology PACS, and other departmental PACS which include PACS solutions for specialties such as ophthalmology, pathology, oncology, radiotherapy, endoscopy, and dentistry. In 2018, the radiology PACS held the largest share of the market as the radiology department of a hospital is where a majority of the imaging studies are handled, managed, and stored.

The medical image management market is segmented on the basis of end users into hospitals, diagnostic imaging centers, and other end users. In 2018, the hospitals segment is expected to account for the largest share of the global medical image management system market. The rising patient population, growing awareness about the benefits of early disease diagnosis, increasing digitization of patient data, and rapid growth in EMR adoption are some of the major factors responsible for the large share of the hospitals segment in the market.

The medical image management market is marked by the presence of several big and small players. Prominent players offering medical image management products include McKesson Corporation (US), GE Healthcare (US), Fujifilm Holdings Corporation (Japan), Merge Healthcare Inc. (US), Agfa-Gevaert Group (Belgium), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Carestream Health, Inc. (US), BridgeHead Software (UK), Novarad Corporation (US), Mach7 Technologies Ltd. (US), and INFINITT Healthcare Co., Ltd. (South Korea).

Request For Sample of the Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=240573338

The medical image management system market is dominated by North America, followed by Europe. The dominance of the North American market is attributed to factors such as the large number of imaging centers in this region, ongoing research activities, and rapid adoption of technologically advanced imaging systems. Additionally, government initiatives towards digitization and increasing adoption of EHR/EMR and data storage & exchange solutions are additional factors driving the adoption of medical image management in this region.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Cancer Immunotherapy Market Insights on Scope and Growing Demands 2021

According to research report the Cancer Immunotherapy Market is projected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0%.

This growth can be attributed to factors such as increasing adoption of target therapy over traditional therapy, emergence of biosimilars, increasing demand for mAbs, high prevalence of cancer.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894

The Lung Cancer application segment is expected to grow at a high CAGR during the forecast period

The current immunotherapies for lung cancer treatment, such as checkpoint inhibitors, monoclonal antibodies, therapeutic vaccines, and other cell therapies, have benefited some patients with advanced lung cancer in the form of durable remission and prolonged survival. The Lung Cancer segment is expected to grow at a high CAGR from 2016 to 2021, owing to the increase in prevalence, patient pool urges a demand for advanced treatment options, and this increases the growth of Cancer Immunotherapy market.

The monoclonal antibody segment is expected to lead the market during the forecast period

Monoclonal antibodies are emerging as the most effective therapeutic agents for the treatment of malignancy. They are currently one of the largest classes of agents approved for the treatment of cancer. Several antibodies are widely adopted, owing to their lesser side effects as compared to chemotherapy. Antibodies are developed to treat several cancers such as lymphoma, leukemia, melanoma, breast cancer, and lung cancer. Cancer monoclonal antibodies are sub-segmented into naked monoclonal antibodies, conjugated monoclonal antibodies, and bispecific monoclonal antibodies.

Increase in adoption of immunotherapy over other treatment options is driving the growth of this market

The treatment options for cancer, such as chemotherapies and radiation therapy, although have more side effects, are more widely used as compared to immunotherapies. The former are all based on destroying cancer cells by irradiation, chemotherapy, or surgery. While they can effectively kill or remove cancer cells, the use of these treatments is often limited because they tend to destroy healthy cells in large numbers as well. As immunotherapies involve the mechanism of enhancing the body’s own immunity using man-made proteins such as monoclonal antibodies, they are accepted worldwide over other treatment options.

Critical questions the report answers:

> Where will all these developments take the industry in the mid to long term?
> What are the upcoming applications for cancer immunotherapy?

While immunotherapy has shown significant promise in the area of cancer treatment, its high cost has served to limit overall patient access. This poses a significant financial burden on low- and middle-income cancer patients. This is restricting the cancer immunotherapy market from growing at its full potential.

The major players in the cancer immunotherapy market are Amgen (U.S.), AstraZeneca (U.K.), F. Hoffman La-Roche (Switzerland), Bayer AG (Germany), Bristol-Myers Squibb (U.S.), Eli Lilly and Company (U.S.), Janssen Global Services, LLC (Belgium), Merck (U.S.), Novartis (Switzerland), and Pfizer (U.S.).

Target Audience for this Report:

> Drug Manufacturers and Suppliers
> Academic Research Institutes
> Hospitals and Clinics
> Research and Development (R&D) Companies
> Business Research and Consulting Service Providers
> Medical Research Laboratories
> Academic Medical Centers and Universities

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197577894

Geographically, the North American market accounted for the largest share of the global cancer immunotherapy market in 2016. The large share can be attributed to factors such as rising number of patients suffering from cancer, increasing adoption rate of immunotherapy, and development of bioinformatics tools are enhancing the drug development process.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Hyperspectral Imaging Systems Market Insights on Scope and Growing Demands 2025

According to the new market research report hyperspectral imaging systems market is projected to reach USD 30.0 billion by 2025 from USD 12.4 billion in 2020, at a CAGR of 19.3%.

The increasing funding and investments, growing industrial applications of hyperspectral imaging are the major factors driving the growth of the hyperspectral imaging systems market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246979343

The Snapshot technology segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the hyperspectral imaging systems market is segmented into pushbroom (line-scanning), snapshot (single shot), and other technologies [whiskbroom (point-scanning), tunable filters (wavelength scan), and imaging FTIR (time scanning)]. The pushbroom segment is estimated to account for the largest share of the hyperspectral imaging market in 2019, while the snapshot segment is projected to register the highest CAGR during the forecast period. This can be attributed to the advantages offered by snapshot hyperspectral imaging systems, which make this technology most suitable for real-time analysis.

PERSONALIZE THIS RESEARCH

> Triangulate with your Own Data
> Get Data as per your Format and Definition
> Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
> Any level of Personalization

In 2019, the cameras segment accounted for the largest share of the market

On the basis of product, the Hyperspectral Imaging Market is segmented into cameras and accessories. Cameras are expected to command the larger share of the market, by product, in 2019. Technological advancements, the development of affordable hyperspectral imaging cameras, and the increasing adoption of hyperspectral technology for defense and industrial applications are driving the growth of the hyperspectral cameras segment.

The prominent players operating in the hyperspectral imaging systems market include Headwall Photonics, Inc. (US), Applied Spectral Imaging, Inc. (US), Corning Incorporated (US), Specim, Spectral Imaging Ltd. (Finland), Telops, Inc. (Canada), Surface Optics Corporation (US), Norsk Elektro Optikk AS (Norway), Resonon, Inc. (US), BaySpec, Inc. (US), Cubert GmbH (Germany), inno-spec GmbH (Germany), XIMEA GmbH (Germany), imec (Belgium), and ChemImage Corporation (US).

Recent Developments

> In 2019, Headwall Photonics launched its advanced sensor payloads (consisting of hyperspectral sensors and LIDAR for unmanned aerial vehicle platforms)
> In 2018, SPECIM opened a new facility in Espoo, Finland
> In 2018, Telops signed a distribution agreement with Infrared Imaging LLC. This agreement strengthened the position of Telops in the US market.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=246979343

North America was the largest regional market for hyperspectral imaging systems in 2019.

The hyperspectral imaging systems market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. Factors such as growth in research funding, technological advancements, and increasing awareness of the benefits of hyperspectral imaging in commercial industries across the region are driving the market for hyperspectral imaging systems in North America.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Surgical Microscopes Market Insights on Scope and Growing Demands 2021

According to research report surgical microscopes market is poised to reach USD 915.6 Million by 2021 from USD 508.1 Million in 2016, at a CAGR of 12.5% from 2016 to 2021.

Growth in this market can mainly be attributed to factors such as the increasing use of fluorescence image-guided surgery (FIGS), increase in the number of surgeries and growing demand for MIS, advancements in healthcare facilities, technological advancements, and customized microscopy solutions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=179225920

The global operating microscopes market is segmented on the basis of application, end user, and region.

Based on application, the global surgical/operating microscopes market is categorized into dentistry, ENT (ear, nose, and throat) surgery, gynecology and urology, neuro and spine surgery, oncology, ophthalmology, plastic and reconstructive surgery, and documentation. In 2016, the neuro and spine surgery segment is estimated to account for the largest share of the global surgical/operating microscopes market. Oncology forms the fastest-growing segment.

On the basis of end user, the surgical microscopes market is segmented into hospitals and outpatient facilities. In 2016, hospitals are estimated to account for the largest share of the operating microscopes market. The growing usage of surgical/operating microscopes in complex neurology, ENT, and dental procedures, and implementation of less-invasive surgical instruments during MIS procedures in hospitals are key market drivers in this end-user segment.

The surgical microscopes market is highly competitive in nature. Some of the major players in this market include Novartis Ag (Switzerland), Danaher Corporation (U.S.), Topcon Corporation (Japan), Carl Zeiss AG (Germany), Hagg-Streit Surgical GMBH (MÖLLER-WEDEL GMBH) (Germany) Accu-Scope Inc., Alltion (Wuzhou) Co., Ltd., Arri Medical (Arri Group), Karl Kaps GmbH & Co. Kg, Takagi Seiko Co. Ltd.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=179225920

In 2016, North America is expected to account for the largest share of the global surgical microscopes market. Factors such as the growing demand for minimally invasive surgical procedures, infrastructural advancements in healthcare facilities, and increase in the number of surgeries are driving the growth of the North American operating microscopes market.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Genome Editing Market worth $11.2 billion by 2025

According to the new market research report "Genome Editing Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics, Drug Discovery & Development), End-User and Region - Global Forecast to 2025", published by MarketsandMarkets™, the global Genome Engineering Market is projected to reach USD 11.2 billion in 2025 from USD 5.1 billion in 2020, at a CAGR of 17.0 % during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000

The market growth is largely driven by factors such as the rise in government funding, growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics. However, the high cost of genomic equipment will restrain the growth of this market.

By technology, the CRISPR segment accounted for the largest share for the genome editing market.

The CRISPR technology segment accounted for the largest share of the genome editing/genome engineering industry in 2019. The large share of this segment can be attributed to the ease of use associated with CRISPR, which gives it a significant advantage over ZFN and TALEN. Another potential advantage is its ability to multiplex.

By end user, the pharmaceutical companies segment accounted for the largest share of the market.

Pharmaceutical companies accounted for the largest share of the genome engineering market, by end user, in 2019. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide. This, in turn, is expected to drive the demand for genome editing in pharmaceutical companies.

By application, the cell line engineering segment accounted for the largest share of the market

Based on application, the genome editing market is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery & development, and other applications. A number of factors, such as the increased funding from governments and private organizations, growing industry focus on stem cell research, and global awareness are driving market growth in this segment.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231037000

North America accounted for the largest share of the market.

The market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the global genome engineering market, closely followed by Europe. The large share of North America can be attributed to factors such as the development of gene therapy in the US, the increasing use of genetically modified crops, the rising prevalence of infectious diseases and cancer, and the availability of research grants and funding.

The market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period, primarily due to increasing investments in research and the application of gene synthesis for genetic engineering in cells, tissues, and organisms.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Veterinary Reference Laboratory Market Insights on Scope and Growing Demands 2025

 According to research report the veterinary reference laboratories market size is projected to reach USD 5.6 billion by 2025 from USD 3.4 billion in 2020, at a CAGR of 10.5%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256972714

Factors such as increasing demand for animal-derived food products and increasing incidence of transboundary and zoonotic diseases are driving the growth of this market amongst the livestock animals during the forecast period.

The veterinary reference lab market is segmented based on the type of service, application, animal, and region. Due to lockdown restrictions and social distancing protocols due to COVID-19 across various countries through the first half of 2020, the market saw a small dip in the number of veterinary clinic visits for routine testing. However, with the launch of new test kits for COVID-19 testing in pets, the second half of the year is expected to see a rise in the total number of tests in reference laboratories, thus compensating for the loss in revenues across the first two quarters.

The immunodiagnostics segment accounted for the largest share of the veterinary reference lab market, by type of service, in 2019.

Based on the type of service, the market is segmented into clinical chemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and others. In 2019, the immunodiagnostics segment accounted for the largest share of the veterinary reference laboratories market. The low cost, low procedural complexity, and greater adoption due to ease of training are some of the key advantages supporting the adoption of this service.

Clinical pathology is the largest application segment of the veterinary reference laboratories market

Based on application, the veterinary reference laboratories market is segmented into clinical pathology, bacteriology, virology, parasitology, productivity testing, pregnancy testing, and toxicology. In 2019, the clinical pathology segment accounted for the largest market share. The rising volume of pathology tests performed is the major factor driving the demand for diagnostic products and consumables for clinical pathology applications.

The companion animal segment accounted for the larger market in 2019.

Based on animal type, the veterinary reference lab market is segmented into livestock animals and companion animals. In 2019, the companion animal segment accounted for the larger share of this market. Growth in this segment is attributed to the growing adoption of companion animals, increasing disposable incomes, growing willingness of companion animal owners to spend more on animal health, and rising incidence of zoonotic diseases.

IDEXX Laboratories, Inc. (US), VCA Inc. (US), GD Animal Health (Netherlands), Zoetis Inc. (US), Neogen Corporation (US), Boehringer Ingelheim (Germany), Marshfield Labs (US), ProtaTek International (US), Texas A&M Veterinary Medical Diagnostic Laboratory (US), Veterinary Diagnostic Laboratory - University of Minnesota (US), and Veterinary Diagnostic Laboratory, Iowa State University (US).

Recent Developments

> In April 2020, IDEXX launched the SARS-CoV-2 (COVID-19) RealPCR Test for companion animals in the US.
> In 6-9 months since October 2019, Zoetis acquired three laboratories that have enhanced the company’s portfolio of testing services with the introduction of microbiology, serology, hematology, chemistry, and many other miscellaneous tests.
> In June 2018, Boehringer Ingelheim acquired Newport Laboratories. The service portfolio of Newport Laboratories is expected to complement BI’s animal business unit portfolio and provide a complete solution for disease prevention in livestock animals.
> In September 2017, Mars, Inc. acquired VCA, Inc. in an all-cash transaction. VCA is now functioning as a separate business unit under Mars Petcare. This acquisition helped Mars in delivering comprehensive solutions in the field of animal testing services.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=256972714

The veterinary reference laboratories market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The increasing adoption of companion animals, the growing pet insurance industry, rising veterinary healthcare expenditure, and the ever-increasing number of veterinary practices are driving the growth of the North American veterinary reference lab market.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Spatial Genomics Market Insights on Scope and Growing Demands 2025

According to the new market research report the global spatial genomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170900551

The major factors driving the growth of the spatial genomics and transcriptomics market are the increasing adoption of spatial genomics and transcriptomics techniques for drug discovery & development and the increasing R&D investments and public-private funding. Additionally, the introduction of technologically advanced instruments for spatial genomics analysis is also boosting the market growth. However, the high capital investments associated with spatial genomics and transcriptomics are a major factor restraining market growth.

Spatial Genomics Market is categorized into major four product categories, techniques, product, application and end user. Among the techniques, spatial transcriptomics techniques segment is expected to grow at the highest CAGR during the forecast period. Growth in this market segmentis attributed to the increasing demand for and high adoption rate of in situ sequencing techniques.

On the basis of technique, the spatial genomics & transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. The spatial transcriptomics techniques segment is further sub-segmented into immunohistochemistry (IHC), in situ hybridization, sequencing technologies, microscopy-based RNA imaging, and other spatial transcriptomics techniques.

Among these, immunohistochemistry segment held a dominant share owing to emergence of multiplex immunohistochemistry/ immunofluorescence (mIHC/IF). Furthermore, spatial genomics analysis technique segment is further sub-segmented into into fluorescence in situ hybridization (FISH), sequencing techniques, and other spatial genomics analysis techniques. The increasing demand for new biomarkers for diagnosis and personalized medicine is a major factor boosting the demand for spatial genomics analysis as a cancer diagnostic tool.

Based on product, the global spatial genomics & transcriptomics market is categorized instruments, consumables, and software. In 2019, consumables accounted for the largest share in the global spatial genomics and transcriptomics market. The growing applications of spatial genomics and transcriptomics in various fields such as drug discovery & development and biomarker identification and the growing use of consumables are the key factors driving the market growth.

Based on application, the spatial genomics & transcriptomics market is segmented translational research and drug discovery & development. The translational research application segment accounted for the largest share of the market in 2019.

The large share of the translational research segment can be attributed to the increasing use of spatial genomics and transcriptomics to determine high-throughput data on the organizational structure of cell content from tissue and cell species.

Based on end users, the spatial genomics market is segmented into into academic & research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. In 2019, the academic & research institutes segment accounted for the largest share of the spatial genomics and transcriptomics market. Market growth can largely be attributed to the increase in research intensity in this end-user segment and the availability of sufficient grants and funds for research.

10X Genomics (US), NanoString Technologies Inc. (US), Illumina Inc. (US), and Bio-Rad Laboratories (US) are the prominent players operating in the spatial genomics and transcriptomics market.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170900551

In 2019, North America held the largest share of 55.6% of the global market, followed by Europe. The large share of the North American regional segment can be attributed to the presence of well-established as well as emerging market players operating in the spatial genomics and transcriptomics market in this region.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

MIS Instruments Market Insights on Scope and Growing Demands 2025

According to research report the global MIS Instruments Market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5% during the forecast period.

Market growth is largely driven by factors such as the advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe. However, the uncertain regulatory framework in the medical device industry is a major factor restraining the growth of this market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682

Handheld instruments accounted for the largest share of the global MIS instruments market in 2018.

Based on product, the MIS instruments market is segmented into handheld instruments, inflation devices, surgical scopes, cutting instruments, guiding devices, electrosurgical & electrocautery instruments, and other instruments. Handheld instruments accounted for the largest share of the MIS devices market in 2018, owing to factors such as the increasing number of surgical procedures and the development of high-dexterity, low-cost articulating laparoscopic handheld surgical instruments.

By type of surgery, the cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018.

Based on type of surgery, the global minimally invasive surgical instruments market is divided into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, cosmetic & bariatric surgery, urological surgery, and other surgeries. The cardiothoracic surgery segment accounted for the largest share of the global MIS devices market in 2018. The large share of this segment can be attributed to the rising prevalence of cardiac diseases, growing awareness about the benefits of early detection of cardiovascular complications, the growing number of coronary and percutaneous cardiology interventions, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.

The hospital segment accounted for the largest share of the global minimally invasive surgical instruments market in 2018.

Based on end user, the global MIS devices market is divided into hospitals and ambulatory surgery centers & clinics. The hospitals segment accounted for the largest share of the market in 2018 due to the large number of minimally invasive surgical procedures performed in hospitals owing to the presence of highly skilled healthcare professionals.

The major companies in the MIS instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US).

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=682

The MIS instruments market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global minimally invasive surgical instruments market, followed by Europe. The large share of the North American market can be attributed to the large volume of surgical procedures performed in North American countries due to early diagnosis and treatment, high cost of procedures as compared to developing regions, increasing number of surgical centers, and growing adoption of minimally invasive surgical techniques.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Spinal Implants Devices Market Growth By Technology, Product and Type - Forecast 2025

According to the market research report the Spinal Implants Market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.

The advancements in spine surgeries technologies, such as the development of safer, more effective, advanced, simple, and easy-to-use spinal implants and devices; the increasing incidence of spinal disorders; and the launch of advanced bone grafting products are some of the key factors driving the growth of the Spinal Implants Devices Market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712

The spinal fusion and fixation technologies segment accounted for the largest share of the Spinal Implants Devices Market in 2019.

On the basis of technology, the Spinal Surgery Devices Market is segmented into spinal fusion and fixation, vertebral compression fracture treatment, motion preservation/non-fusion, and spinal decompression technologies. The spinal fusion and fixation technologies segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the rising incidence of target diseases (such as degenerative disc disease and spinal stenosis) with the growing geriatric population across the globe, a growing number of spinal fusion procedures, and technological advancements in spinal fusion techniques and bone grafting procedures.

The open surgeries segment accounted for the largest share of the Spinal Implants Devices Market in 2019.

Based on the type of surgery, the market is segmented into open and minimally invasive surgeries. The open surgeries segment accounted for the largest share of the Spinal Surgery Devices Market in 2019. The large share of this segment can be attributed to the increasing preference for open spine surgeries among medical professionals, rising incidence of spinal deformities, and technological advancements in spinal fusion surgeries. In addition, some spine procedures, such as spinal implant insertions, can only be done through open surgeries, which is another major factor supporting market growth.

The thoracic fusion and lumbar fusion devices segment accounted for the largest share of the Spinal Surgery Devices Market in 2019.

Based on product, the market is segmented into thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, non-fusion devices, vertebral compression fracture treatment devices, spinal decompression devices, and spine bone stimulators. The thoracic fusion and lumbar fusion devices segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the increasing incidence of lumbar degenerative disc disease and the growing number of product launches.

North America dominates the Spinal Implants Market.

The Spinal Implants Devices Market is segmented into five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market can be attributed to its highly developed healthcare infrastructure and reimbursement systems and high patient awareness and physician education. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the improving healthcare infrastructure, rising awareness, improving reimbursement scenario, and the growing insurance coverage in several APAC countries.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=712

The major players operating in the Spinal Implants Market are Medtronic (Ireland), DePuy Synthes (US), NuVasive, Inc. (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Zimmer Biomet Holdings, Inc. (US), Globus Medical, Inc. (US), Spineart (Switzerland), Kuros Biosciences AG (Switzerland), Orthofix International N.V. (US), Abbott Laboratories (US), RTI Surgical, Inc. (US), Boston Scientific (US), SeaSpine Holdings Corporation (US), ulrich GmbH & Co. KG (Germany), Bioventus, LLC (US), Colfax Corporation (US), Meditech Spine, LLC (US), and Implanet (France).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
sales@marketsandmarkets.com

Medical Wearables Market Insights on Scope and Growing Demands 2025

According to research report the global medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a high CAGR of 21.4%

The growing adoption of smartphones, increasing penetration of 4G/5G networks, increasing utilization of connected devices for the management of chronic diseases, rising focus on cost containment in healthcare delivery, rising focus on patient-centric healthcare delivery and the increasing demand for home healthcare services are some of the key factors driving the greater uptake of mobile technologies among both patients and healthcare professionals.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52426876

The vital sign monitoring device segment accounted for the largest share of the medical wearables market in 2019

Based on device type, the vital sign monitoring segment accounted for the largest share of the Clinical Wearable Market in 2019. The large share of this segment can be attributed to the high and growing penetration of smartphones and significant technological advancements in medical wearable devices, which have helped improve the treatment outcomes for patients. Population aging is poised to become one of the most significant social transformations of the twenty-first century, with implications for nearly all sectors of society, including labor and financial markets, the demand for goods and services, such as housing, transportation and social protection, as well as family structures and intergenerational ties.

The Patches product segment accounted for the largest share of the Medical Wearable market in 2019

Based on product type, the patches segment accounted for the largest share of the Clinical Wearable Market in 2019. The large share of this segment can be there have been significant technological advancements in medical wearable devices, which have helped improve the treatment outcomes for patients. Growing use of high-tech devices that are compact, user-friendly, and come with a better graphical user interface for easy visibility of resulted data are helping to increase the market penetration of clinical-grade wearables. These wearables are playing an integral role in treating and monitoring various medical conditions in patients and driving better health outcomes.

The Long-term care centers, nursing homes, and assisted-living facilities segment accounted for the largest share and highest growth of the Clinical-Grade Wearable market in 2019

Based on the Clinical grade wearables market by end-user, the end-user is segmented into Long-term Care Centers/ Assisted Living Facilities/Nursing Homes, Hospitals, Ambulatory Care Centers, and Home/Patients. In 2019, the Long-term Care Centers/ Assisted Living Facilities/Nursing Homes accounted for the largest share and highest growth of the Medical Wearable market. New communication technologies majorly drive growth in this market segment are supporting the transition of healthcare delivery from institution-centric frameworks to patient-centric care. The number of long-term care centers, assisted-living facilities, and nursing homes is increasing due to the growing geriatric population, the rising prevalence of chronic diseases, and the increasing healthcare expenditure.

Based on the region, North America accounted for the largest share of the Clinical-Grade Wearable market in 2019

Based on region, the Medical Wearable market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share in 2019. This is due to the increasing penetration of smartphones, rising prevalence of chronic and lifestyle disorders, increasing healthcare costs, increasing demand for better healthcare services, government initiatives to promote digital health, robust penetration of 3G and 4G networks, and the rising awareness of self-health management.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=52426876

The global medical wearables market is highly fragmented, with many large and small firms operating at the regional and country levels. The prominent players in the global Clinical-Grade Wearable market are Medtronic plc. (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Biotelemetry Inc.(US), Apple, Inc. (US ), Dexcom Inc. (US), Abbott Laboratories(US), Masimo Corporation(US), GE Healthcare (US), Bio-Beat Technologies (Israel), iRhythm Technologies, Inc.(US), VitalConnect (US), Minttihealth (US), Preventice Solutions, Inc. (US), Contec Medical Systems Co.Ltd(China), Biotricity Inc.(US), Verily Life Sciences. (US), Cyrcardia Asia Limited (Hong Kong ), ten3T healthcare (India), VivaLnk, Inc.(US).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Weight Loss Management Market Market Growth by Fitness, Diet and Services - Forecast 2022

According to market research report Weight Loss Management Market to grow from USD 175.94 billion in 2017 to USD 245.51 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.

The growth of this market is majorly attributed to the growing rate of obesity, increasing prevalence of lifestyle diseases, and increasing number of bariatric surgeries.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=1152

The fitness equipment segment is projected to grow at the highest CAGR during the forecast period.

By equipment, the weight loss management market is segmented into fitness equipment and surgical equipment. The fitness equipment segment is estimated to register the highest growth rate during the forecast period. The high growth in this segment can primarily be attributed to the continuous technological advancements in fitness equipment and growing accessibility to gyms.

Beverages segment to dominate the market in 2017

Based on diet, the weight loss and weight management market is segmented into meals, beverages, and supplements. In 2017, the beverages segment is expected to account for the largest share of the weight loss and weight management market. Growth in this segment is majorly driven by the growing diabetic population across the globe.

The Weight Loss Management Market is highly competitive, with the presence of several small and large players. Some of the players operating in this market include Atkins Nutritionals (US), Herbalife (US), Nutrisystem (US), Ethicon (US), Covidien (US), Slimming World (UK), The Gold’s Gym (US), Duke Diet & Fitness Center (US), Apollo Endosurgery (US), Brunswick (US), Amer Sports (Finland), Johnson Health Technology (Taiwan), Technogym (Italy), Weight Watchers (US), Jenny Craig (US), eDiets.com (US), VLCC Healthcare (India), Equinox (US), Life Time Fitness (US), Fitness First Group (US), and Town Sports (US).

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1152

North America to dominate the weight loss and weight management market

In 2017, North America is expected to dominate the global weight loss management market primarily due to factors such as the increasing incidence of obesity and chronic diseases, rising awareness about nutrition and healthy lifestyles, and growing number of fitness centers in the region. In 2017, Europe is expected to account for the second-largest share of this market. Rising prevalence of obesity and increasing government support and initiatives to tackle obesity-related problems are the major factors supporting the growth of the weight loss management market in this regional segment.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Antimicrobial Susceptibility Testing Market Growth by Application, Product and Method - Forecast 2025

According to the new market research report Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984

The growth of the antibacterial susceptibility testing systems market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods. Moreover, rising R&D investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.

Based on type, the antibacterial susceptibility testing systems segment is expected to account for the largest share of the AST Market in 2019

Based on type, the antibacterial susceptibility testing systems market has been segmented into the antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing, and susceptibility testing types. Among these, the antibacterial susceptibility testing segment dominated the market in 2019. The major share of the segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries.

The susceptibility testing disks subsegment of manual antimicrobial susceptibility testing products to hold major market share by 2025

Based on the product, the antimicrobial susceptibility testing market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The manual susceptibility testing products segment is further divided into susceptibility testing disks, MIC strips, and susceptibility testing plates. Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019. The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries. Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).

The clinical diagnostics segment is expected to register the highest growth rate during the forecast period

Based on application, the antimicrobial susceptibility testing market has been segmented into the market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other applications. Significant market growth in the clinical diagnostics segment can be attributed to the rising burden of infectious diseases, the growing burden of antimicrobial resistance, and new product launches in the market.

North America is expected to dominate the global antibacterial susceptibility testing systems market in 2019

North America, comprising the US and Canada, accounted for the largest share of the antimicrobial susceptibility testing market in 2019. Technological advancements in rapid antimicrobial susceptibility testing systems, rising incidence of infectious diseases (such as AIDS, tuberculosis, and pertussis), and government support for antimicrobial resistance-related research are the major factors driving market growth in North America. As AST through conventional methods is a lengthy process, customers in North America are moving towards rapid AST techniques, which require minimal reagents. This trend will have a positive impact on the automated instruments market.

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=206359984

bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Creative Diagnostics (US), Synbiosis (UK), Bioanalyse (Turkey), ZHUHAI DL BIOTECH Co., Ltd. (China), Roche Diagnostics Limited (Switzerland), CONDALAB (Spain), Genefluidics, Inc. (US), Accelerate Diagnostics, Inc. (US), Merck KGaA (US), Hi-Media Laboratories (India), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Italy), ELITechGroup (France), Mast Group Ltd. (UK), Biotron Ltd (Australia), InvivoGen (US), MP Biomedicals (US), QuantaMatrix Inc. (South Korea), and PML Microbiologicals Inc. (US), among others are some of the major players operating in the global Antimicrobial Susceptibility Testing Market.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

Liquid Biopsy Market Insights on Scope and Growing Demands 2022

 According to the market research report Liquid Biopsy Market is expected to reach $2,047.9 Million by 2022 from an estimated $715.7 Million in 2017, at a CAGR of 23.4%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=13966350

Some of the key factors driving the growth of this market include increasing preference for noninvasive procedures, increasing prevalence of cancer and availability of funding for liquid biopsy R&D.

By clinical application, the therapy selection segment is expected to account fors the largest market share in 2017.

Based on clinical application, the liquid biopsy market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The therapy selection segment is expected to account for the largest share of the liquid biopsy devices market in 2017. This is due to the ability of therapy selection to detect advanced-stage cancers (stage III and IV), followed by increasing studies on liquid biopsy and advancements made in this field to also aid in detection of early-stage cancers.

By application, the cancer segment is expected to account for the largest market share in 2017. Based on application, the market is segmented into cancer and non-cancer applications (which includes reproductive health and organ transplant diagnostics). In 2017, cancer applications segment is expected to account for the largest share of the liquid biopsy market.

By circulating biomarkers, circulating tumor cells is expected to account for the largest market share in 2017. Based on circulating biomarkers the market is categorized into circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. In 2017, the circulating tumor cells segment is expected to account for the largest share of the liquid biopsy market.

By product, the assay kits segment is expected to account for the largest share of the market in 2017. On the basis of product, the market is broadly segmented into assays kits, instruments, and services. In 2017, the assay kits segment is expected to account for the largest share of this market.

Based on end user, the liquid biopsy market is segmented into reference laboratories, hospitals and physician laboratories, academic and research centers, and other end users (public health laboratories, pathology laboratories, and small molecular laboratories). Reference laboratories form the largest and fastest-growing end-user segment of the liquid biopsy market. The can be attributed to the large volume of tests being outsourced to reference laboratories from oncologists and hospitals.

North America is expected to account for the largest share of the global liquid biopsy market in 2017, while Asia Pacific is expected to witness the highest growth during 2017 to 2022. Growing demand for non-invasive treatment, rising incidence of cancer, and improving healthcare infrastructure are driving the growth of the liquid biopsy market.

The key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).

Request For Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=13966350

Recent Developments

> In March 2017, QIAGEN N.V. (Netherlands) launched AdhaTest Prostate Cancer Panel AR-V7. AdnaTest Prostate Cancer Panel AR-V7 A are used to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer.
> In March 2017, Roche Diagnostics (Switzerland), launched AVENIO circulating tumor DNA (ctDNA) Analysis Kits. The kits include all reagents, bioinformatics and software to make ctDNA testing accessible to all NGS laboratories.
> In April 2017, Myriad Genetics Inc. (US), partnered with BeiGene (Cayman Islands). BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer. As per this partnership, BeiGene will use Myriad’s myChoice HRD and BRACAnalysis CDx companion diagnostic tests to support the clinical development of its novel PARP inhibitor, BGB-290.
> In April 2017, Menarini Silicon Biosystems (Italy), Inc. acquired Janssen Diagnostics, LLC. (US). This acquisition of Janssen Diagnostics' business related to CELLSEARCH Circulating Tumor Cell System. The acquisition marks Menarini-Silicon Biosystems’ first entry into the US diagnostics market.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com

AI in Genomics Market Growth By Offering, Functionality, Application and Region

According to the new market research report AI in Genomics Market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899

The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.

Based on offering, the Artificial Intelligence In Genomics Market is segmented into software and services. The software and services segment accounted for largest share of the global AI in genomics market in 2019. Software is needed to generate new insights from large-scale datasets and help understand genomic variations, thus enhancing the search for disease-causing variants and reducing clinical analysis times. The benefits offered by AI in software are driving its adoption among end users.

Based on functionality, the AI in genomics market is segmented into genome sequencing, gene editing, clinical workflows, and predictive genetic testing & preventive medicine. Genome sequencing was the largest functionality segment in this market in 2019 and is estimated to grow at highest CAGR in coming years. The large share of this segment can be attributed to the use of AI solutions to identify chromosomal disorders, dysmorphic syndromes, teratogenic disorders, and single-gene disorders.

In 2019, North America accounted for the largest share of the AI in genomics market, followed by Europe. The large share of North America can be attributed to the increasing research funding and government initiatives for promoting precision medicine in the US.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=36649899

Prominent players in the market are IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK),Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), Engine Biosciences Pte. Ltd. (US)

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Lab Informatics Market Insights on Scope and Growing Demands 2024

 

According to research report the Lab Informatics Market is estimated to reach USD 3.8 billion by 2024 from USD 2.6 billion in 2019, at a CAGR of 7.5% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203037633

The increasing need for laboratory automation; the development of integrated lab informatics solutions; the need to comply with regulatory requirements; and the growing demand in biobanks/biorepositories, academic research institutes, and CROs are the major factors driving the growth of the laboratory informatics market. On the other hand, lack of integration standards and high maintenance and services cost are expected to restrain the growth of this market in the coming years.

The services segment accounted for the largest share of the market in 2018.

Based on components, the Lab Informatics Market is segmented into services and software. The services segment dominated this market in 2018. The large share of the services segment can be attributed to the growing technological advancements in solution offerings by various vendors, increasing adoption of cloud-based solutions, growing need for consulting services, and the recurring nature of services. Furthermore, in terms of IT usage and skill, the life science industry relies heavily on service providers.

The cloud-based models segment is expected to grow at the highest CAGR during the forecast period.

On the basis of deployment model, the laboratory informatics market is segmented into on-premise, cloud-based, and remotely hosted models. The cloud-based models segment is expected to grow at the highest CAGR during the forecast period. Factors such as on-demand self-serving analytics, no upfront capital investment for hardware, extreme capacity flexibility, and a pay-as-you-go pricing model will boost the demand for cloud-based laboratory informatics solutions in the coming years. However, data transfer complexities and data security concerns may hinder the growth of this market segment.

The laboratory informatics market is diversified and highly competitive, with a large number of players competing for market space. The prominent players in the market are Thermo Fisher Scientific Inc. (US), LabVantage Solutions, Inc. (US), LabWare (US), Abbott Informatics (US), LabLynx, Inc. (US), Waters (US), Agilent Technologies, Inc. (US), Autoscribe Informatics (US), Dassault Systèmes (Paris, France), LABWORKS LLC (US), KineMatik (Ireland), Accelerated Technology Laboratories (ATL) (US), and PerkinElmer Inc. (US).

Recent Developments

> In August 2018, Waters (US) signed an agreement with Restek Corporation (US). Under this agreement, Waters and Restek Corporation agreed to provide training and application support of GC-MS methods and workflows for pesticide monitoring and screening to food safety laboratories.
> In May 2018, Agilent Technologies (US) acquired Genohm (Switzerland). This acquisition enhanced Agilent’s current software portfolio by adding LIMS and workflow management, thus expanding the company’s ELN capabilities.
> In February 2018, Autoscribe Informatics opened a new operation facility in Australia to expand its LIMS customer base to Australia and New Zealand.
> In March 2017, Thermo Fisher Scientific acquired Core Informatics. This acquisition enhanced Thermo Fisher’s existing informatics solutions and its cloud platform, including its laboratory information management systems (LIMS), electronic laboratory notebook (ELN) technologies, and scientific data management solutions (SDMS).

Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=203037633

Geographically, the Lab Informatics Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America dominated the market, followed by Europe. Growth in the North American market is supported by the growing demand for the integration of laboratory systems, rising government funding for research, growth in biobanks, need for early drug discovery, easy availability of laboratory informatics products and services, and stringent regulatory requirements across industries.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com